Eli Lilly and Company (LLY)

LLY (NYSE:Drugs)
$59.42
pos +0.47
+0.80%
Today's Range: 58.28 - 59.69 | LLY Avg Daily Volume: 5,641,500
Last Update: 04/15/14 - 4:00 PM EDT
Volume: 4,481,194
YTD Performance: 15.59%
Open: $59.19
Previous Close: $58.95
52 Week Range: $47.53 - $60.46
Oustanding Shares: 1,119,713,084
Market Cap: 65,449,813,484
6-Month Chart
TheStreet Ratings Grade for LLY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 5 5 5
Moderate Buy 0 0 0 0
Hold 5 5 6 5
Moderate Sell 1 1 1 1
Strong Sell 2 3 2 3
Mean Rec. 2.45 2.74 2.59 2.74
Latest Dividend: 0.49
Latest Dividend Yield: 3.30%
Dividend Ex-Date: 02/12/14
Price Earnings Ratio: 13.75
Price Earnings Comparisons:
LLY Sector Avg. S&P 500
13.75 13.50 28.25
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
12.41% 2.50% 64.90%
GROWTH 12 Mo 3 Yr CAGR
Revenue 2.30 0.00 0.00
Net Income 14.60 -0.08 -0.03
EPS 18.00 -0.05 -0.02
Earnings for LLY:
EBITDA 6.99B
Revenue 23.11B
Average Earnings Estimates
Qtr (03/14) Qtr (06/14) FY (12/14) FY (12/15)
Average Estimate $0.70 $0.65 $2.80 $3.15
Number of Analysts 10 8 10 12
High Estimate $0.76 $0.69 $2.84 $3.45
Low Estimate $0.62 $0.58 $2.76 $2.78
Prior Year $1.14 $1.16 $4.15 $2.80
Growth Rate (Year over Year) -38.60% -43.86% -32.51% 12.52%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Update
Apr 14, 2014 | 7:54 AM EDT
LLY upgraded to Hold from Underperform, Jefferies said. Material downside catalysts removed. $54 price target. 
Bullish
Apr 08, 2014 | 8:01 AM EDT
LLY was upgraded from Underperform to Market Perform, BMO Capital said. $62 price target. Company has been executing well, versus low e...

Lots of Lilly Momentum Real Money Pro($)

And the stock now has layers of support in place.
Bullish
Feb 12, 2014 | 8:15 AM EST
ELI raised its number, Jefferies said. Strong performance in Cymbalta, Humalog, Alimta, and Cialis. $44 price target and Underperform r...
Bearish
Feb 12, 2014 | 7:10 AM EST
Leerink Swann Global Healthcare Conference (Day 1 of 2) - 02/12/14 - 02/13/14 New York, NY

The Cloud Is the Prescription Real Money Pro($)

Medidata Solutions is focusing its cloud-computing offerings on the pharmaceutical industry.
Bullish
Jan 31, 2014 | 8:26 AM EST
LLY estimates were raised through 2018, MKM Partners said. Company is seeing higher sales. Buy rating and new $61 price target. 
Bearish
Jan 08, 2014 | 8:12 AM EST
LLY was downgraded from Market Perform to Underperform, BMO Capital said. $50 price target. Expect lower results from the clinical pipe...

Morning Market Look Real Money Pro($)

Let's take a look at the overnight and early-morning price action in the major asset classes.

Columnist Conversations

After the close Yahoo reported another pathetic quarter. Revenue rose 1.2% to $1.09 billion vs the $1.08 bin c...
Wow, have not seen an intraday rally like today's to the upside like this for quite some time. Encouraging we...
Today's probing low followed by a recovery signals to us that the seasonal pattern of April mid-month strength...
Traders couldn't ask for much bigger swings than we've been seeing over the past two sessions. It's been pret...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.